Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:21 PM
Ignite Modification Date:
2025-12-24 @ 12:21 PM
NCT ID:
NCT05927961
Eligibility Criteria:
Inclusion Criteria:
* According to the 2020 guidelines for primary aldosteronism, patients with positive primary aldosteronism confirmed test;
* Patients with predominant unilateral aldosterone secretion at AVS; adrenal CT suggesting unilateral adrenal adenoma (\> 0.8cm diameter) and no abnormalities in contralateral adrenal morphology.
* Patients who agreed to do the adrenalectomy.
Exclusion Criteria:
* adrenal CT suggests abnormal bilateral adrenal morphology or unilateral nodules.
* glucocorticoids can treat aldosteronism (GRA) and familial aldosteronism.
* other secondary hypertension: renal parenchymal hypertension, renal artery stenosis, Cushing syndrome, adrenal myeloid hyperplasia, aortic narrowing, obstructive sleep apnea hypoventilation syndrome.
* any other unsuitable condition for surgery.
* Patients who refused to perform adrenalectomy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT05927961
Study Brief:
Protocol Section:
NCT05927961